How do you reshape drug development with AI without sacrificing safety? Few have faced that question at higher stakes than Dr. Stephen Hahn. The former @FDA Commissioner and current Nucleus RadioPharma CEO keynotes Rev Philadelphia on 5/12. RSVP: https://
hubs.ly/Q04c7_Dj0

→ View original post on X — @dominodatalab,